Palantir vs. UiPath: Which AI-First Software Stock is a Better Buy?

The article compares Palantir (PLTR) and UiPath (PATH), both AI-first software stocks, concluding that UiPath presents a stronger "Buy" opportunity despite Palantir's robust growth. Palantir reported Q2 2025 U.S. commercial revenue up 93% year-over-year and contract value up 222%, driven by its AIP platform, but trades at a high 82X forward sales multiple. In contrast, UiPath posted Q2 2026 revenue growth of 14% to $362 million and 11% ARR growth to $1.72 billion, supported by strategic partnerships, and offers a more attractive valuation at 4.22X forward sales, making it a value-driven choice in the evolving AI software landscape.

Analysis

The AI-first software sector presents a distinct choice between Palantir (PLTR) and UiPath (PATH), centered on a growth-versus-valuation trade-off. Palantir is demonstrating explosive expansion, primarily through its Artificial Intelligence Platform (AIP). In its second quarter, the company reported a 93% year-over-year surge in U.S. commercial revenues and a 222% increase in total U.S. commercial contract value, underscoring rapid market penetration and customer adoption. This hyper-growth, with Zacks Consensus Estimates projecting 46% sales growth for 2025, is reflected in a premium forward sales multiple of 82X, significantly above its median. In contrast, UiPath offers a more stable, value-oriented profile. It posted 14% year-over-year revenue growth to $362 million and an 11% rise in annual recurring revenues to $1.72 billion in its recent quarter. UiPath's strengths lie in its sticky subscription model, evidenced by a 108% net retention rate, and strategic partnerships with tech giants like Microsoft, Amazon, and Salesforce. This steady performance is available at a far more modest valuation, with a forward sales multiple of 4.22X, which is below its 12-month median.

Key Decisions for Investors

• Investors must decide between Palantir's high-growth narrative, backed by a 93% surge in U.S. commercial revenue, and its accompanying premium 82X forward sales multiple, or UiPath's more attractive valuation at 4.22X forward sales with steadier 14% revenue growth.
• For those considering Palantir, continued momentum in its U.S. commercial segment is critical to justifying its elevated valuation, making the next quarter's contract and customer growth figures key indicators to watch.
• UiPath may appeal to value-focused investors, as its current valuation does not appear to fully price in the potential upside from its strong partner ecosystem and high 108% net retention rate, which could accelerate future growth.
• Given that EPS estimates for both companies are trending upward, the primary decision factor is risk appetite regarding valuation, as both firms are positioned to benefit from expanding enterprise AI adoption.